Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior - Test2 - elhamkhani - TriplyDB

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

http://www.wikidata.org/entity/Q28286238

about

Psychedelics and mental health: a population study The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Prediction of psilocybin response in healthy volunteers GPCR oligomers in pharmacology and signaling Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.A safe lithium mimetic for bipolar disorder Human hallucinogen research: guidelines for safety The HIV antiretroviral drug efavirenz has LSD-like properties The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia The behavioral pharmacology of hallucinogens Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo Arresting serotonin Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.Identification of a serotonin/glutamate receptor complex implicated in psychosis Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs Lysergic acid diethylamide: a drug of 'use'?The role of serotonin 5-HT2A receptors in memory and cognition Preclinical models of antipsychotic drug action.Recent advances in the neuropsychopharmacology of serotonergic hallucinogens Real-time impedance-based cell analyzer as a tool to delineate molecular pathways involved in neurotoxicity and neuroprotection in a neuronal cell line.A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?A functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2 Plato's cave algorithm: inferring functional signaling networks from early gene expression shadows Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain 5-HT 2A receptor deficiency alters the metabolic and transcriptional, but not the behavioral, consequences of chronic unpredictable stress Psychedelics The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia G protein-coupled receptor heterocomplexes in neuropsychiatric disorders.

P2860

Q21089784-D38ABB09-034A-4FAB-B36B-D8EF042E38FF Q21129387-0CED03BB-F244-40B3-A53A-F13F566E1872 Q21134798-1F354939-E4E5-493A-925E-ED4ED39FFC96 Q21198901-F29F901F-7961-43F3-B669-9F3F6CA5ED7A Q22241778-5DD41771-610E-4F2F-8C65-C45E6C30A190 Q22251267-2F6F3EE1-C643-405A-8999-145F94B4D46F Q24594672-36687804-56A9-4BE6-BB1A-CBA59C847E0E Q24594834-88CD3001-25D8-4846-811B-E4FD70A86E19 Q24595389-03D1C34C-60D2-4934-A3C5-303888DE490F Q24600175-04ABC195-A8D6-4827-A0F7-9654A50720B5 Q24600704-B3FCB4AC-91DC-4B2D-9C1F-983C5E22A991 Q24608183-57C9F40A-BF44-4344-8066-F8E77E777B2B Q24620468-C55B3D8B-BC47-4591-97A0-893D50082212 Q24620764-3A1CBF20-1956-452F-BE8D-21ED84102658 Q24630429-DF160A82-C221-4B4A-89B1-6BD776A37178 Q24630645-7A4F78ED-C2A6-4D5A-8E51-6EDF94C888D8 Q24632803-74FCAFDF-7DFA-44D4-A18C-2D0D5E01734D Q24645656-B4B512EC-9A2D-4B7F-AAFA-F9EFCBF4946C Q24647416-AA4D4428-D23C-4583-A64C-72409DDCFF7D Q24647492-2A684F24-2EE5-473B-8018-3171E5265BA8 Q24649779-35BEDE80-E06F-4565-9907-FDA3C1AF7BF3 Q24652204-C5AE9C9C-2C22-4B54-B862-42DE2EE6AB85 Q24655484-27FC486A-691A-4FF7-953A-B3BCB9716760 Q24676304-DBBDAC9B-0CDC-4E67-B43E-66F38E62BD0A Q26744729-A76F288A-1494-4264-BA39-3B6139652F88 Q26746133-D85E668C-F340-4EBA-8254-1CDC8B8FE10A Q26779278-F052023B-1B4E-4C29-AC79-2E023260C155 Q26827502-0B966C7A-1D62-4471-83F4-98CAF1F9EA25 Q27027381-97CD50C4-D3CF-42A1-998D-3E7EB04CC318 Q27302931-C7691CBA-A6EA-405D-A8D4-25CE6166CFED Q27303855-9A260053-DDC5-4B89-9946-C2A1D2D7CC8E Q27347603-DB5EFAF3-B09D-463F-B492-8A0537766EA3 Q28080944-D52606AE-2CF8-4F6E-A798-FC3397CEF1C9 Q28249697-37108E15-76B2-4A79-B3F4-8A8269D3C0CD Q28474678-C696DD96-549B-4D14-89CE-B4E66FB9C164 Q28543523-1A02D0E2-F196-4E41-A95E-2CA768B440F9 Q30212112-F984B746-ACA1-47E6-8841-D0DC97252853 Q30359998-9BCF0B8E-E11D-49D5-B0F3-C4D1662560B3 Q30371933-1FBAB33D-4FBC-4116-8ABE-1E69C821AE71 Q30385233-55139F26-9BE0-40FF-8B11-F54682A37F91

P2860

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

http://www.wikidata.org/entity/Q28286238

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Hallucinogens recruit specific ...... ng pathways to affect behavior

@ast

Hallucinogens recruit specific ...... ng pathways to affect behavior

@en

Hallucinogens recruit specific ...... ng pathways to affect behavior

@nl

type

label

Hallucinogens recruit specific ...... ng pathways to affect behavior

@ast

Hallucinogens recruit specific ...... ng pathways to affect behavior

@en

Hallucinogens recruit specific ...... ng pathways to affect behavior

@nl

prefLabel

Hallucinogens recruit specific ...... ng pathways to affect behavior

@ast

Hallucinogens recruit specific ...... ng pathways to affect behavior

@en

Hallucinogens recruit specific ...... ng pathways to affect behavior

@nl

P1433

Q28286238-9C6209FA-A4E3-4CBB-A977-8D9F26454C4B

P1476

Q28286238-195EAEE4-1ED0-4C1F-A5D8-CFB431130D7A

P2093

Q28286238-082B083A-BEAB-48B7-B74B-384167E87443

Q28286238-1818FD10-F5D0-49AC-9CFE-4A3355C9E50E

Q28286238-246F8BF9-A306-4F99-8FF9-B90E0B2F437B

Q28286238-43B57A6A-2F39-4F80-8A5F-F62BC0F71989

Q28286238-46A2524A-0F1C-4163-A4A7-C15134F700FE

Q28286238-5E5B37A5-8B88-4B6A-A987-E2F1D31E9531

Q28286238-665B5B24-8317-46D3-AB2B-A29945773B20

Q28286238-9286A596-0DF1-40A1-8145-790F726323F3

Q28286238-93C8A21D-8389-482F-B1C5-9045B4569497

Q28286238-9E75BFF9-B025-4C2C-A284-C64A2C471C50

P304

Q28286238-E28CE2C9-C43B-4952-80CD-25BFE2BBD25E

P31

Q28286238-AF64DEE6-88E9-455B-9244-ACD6EE3C43F2

P3181

Q28286238-8BDACAF0-DDF7-4992-9048-9446E9871D28

P356

Q28286238-A880169B-4F04-4F82-8094-D93D9F96A67A

P407

Q28286238-648C5D06-BB41-49BC-9D7A-03B93F4FD1F5

P433

Q28286238-342731E6-41A4-4C2A-BF33-02FBA48B8CC7

P478

Q28286238-AA8C22D0-9025-4C84-A4CB-27E69A819069

P50

Q28286238-D28E6276-7DA9-45AD-A3B0-5EDA3D1E5421

P577

Q28286238-9CEE4ED8-E351-481F-B18D-407A102393BA

P5875

Q28286238-4EA19EA8-B2E5-419D-9C7E-69E9B2FC5FCC

P698

Q28286238-DE140D33-FEE2-4AF1-97D0-F881E9E47AE7

P3181

P356

J.NEURON.2007.01.008

P1433

P1476

Hallucinogens recruit specific ...... ng pathways to affect behavior

@en

P2093

Alena Lira

http://www.w3.org/2001/XMLSchema#string

Javier González-Maeso

http://www.w3.org/2001/XMLSchema#string

Jay A Gingrich

http://www.w3.org/2001/XMLSchema#string

Lidija Ivic

http://www.w3.org/2001/XMLSchema#string

Maria Bradley-Moore

http://www.w3.org/2001/XMLSchema#string

Mingming Zhou

http://www.w3.org/2001/XMLSchema#string

Noelia V Weisstaub

http://www.w3.org/2001/XMLSchema#string

Pokman Chan

http://www.w3.org/2001/XMLSchema#string

Qiang Zhou

http://www.w3.org/2001/XMLSchema#string

Rosalind Ang

http://www.w3.org/2001/XMLSchema#string

P304

439-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1462062

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.NEURON.2007.01.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Stuart C Sealfon

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6533410

http://www.w3.org/2001/XMLSchema#string

P698

17270739

http://www.w3.org/2001/XMLSchema#string